TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Glycorex Transplantation AB (publ)
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
22,834
|
20,125
|
24,134 |
| Financial expenses |
464
|
259
|
165 |
| Earnings before taxes |
-7,145
|
-20,395
|
-5,693 |
| EBITDA |
-728
|
-6,004
|
166 |
| Total assets |
32,670
|
44,226
|
64,202 |
| Current assets |
12,010
|
17,556
|
30,365 |
| Current liabilities |
9,210
|
9,759
|
10,573 |
| Equity capital |
21,506
|
29,580
|
49,692 |
| - share capital |
2,398
|
2,480
|
2,467 |
| Employees (average) |
20
|
23
|
22 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
65.8%
|
66.9%
|
77.4% |
| Turnover per employee |
1,142
|
875
|
1,097 |
| Profit as a percentage of turnover |
-31.3%
|
-101.3%
|
-23.6% |
| Return on assets (ROA) |
-20.4%
|
-45.5%
|
-8.6% |
| Current ratio |
130.4%
|
179.9%
|
287.2% |
| Return on equity (ROE) |
-33.2%
|
-68.9%
|
-11.5% |
| Change turnover |
3,375
|
-4,133
|
5,288 |
| Change turnover % |
17%
|
-17%
|
28% |
| Chg. No. of employees |
-3
|
1
|
-2 |
| Chg. No. of employees % |
-13%
|
5%
|
-8% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.